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Meta-analysis of randomized
controlled trials of cognitive
decline after on-pump versus
off-pump coronary artery bypass
graft surgery
To the Editor:
We read with interest the meta-analysis of
randomized studies of neurocognitive de-
cline after on-pump versus off-pump
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diabetes mellitus and triple-
vessel disease undergoing
coronary artery bypass grafting
after previous percutaneous
coronary intervention
To the Editor:
In their recent article, Thielmann and col-
leagues1 concluded that previous percutane-
ous coronary intervention (PCI) in patients
with diabetes and triple-vessel disease is
an independent predictor of death and major
adverse cardiac events for patients undergo-
ing coronary artery bypass grafting
(CABG). We wish to point out a few con-
founders and issues that we believe readers
should take into consideration when inter-
preting this study. First, as acknowledged
by the authors, the statistical analysis was
based on pooled registry data, obtained in
a nonrandomized manner and analyzed ret-
rospectively. In addition, the preoperative
characteristics differed significantly be-
tween groups in important prognostic
markers of adverse outcome after CABG,
including renal dysfunction and previous
myocardial infarction.2 Interestingly, the
same univariate analysis that identified pre-
vious PCI as a predictor of adverse outcome
after CABG did not do the same for renal
impairment. If the authors conclude the for-
mer, are they then implying that previous
PCI is a more potent predictor of adverse
outcome than the well-recognized problem
of renal impairment?
In addition, patients who underwent
CABG after PCI constituted a cohort who
had already been failed by PCI in combina-
tion with optimal medical therapy as a result
of either restenosis or progression of de
novo disease. This suggests that these pa-
tients were in effect a cohort with aggres-
sive coronary disease, and that they might
have had poorer outcomes no matter what
strategy was offered first. It is therefore dif-
ficult to compare this cohort with a group of
patients with coronary artery disease with-
out previous treatment failure who were
offered CABG as a first revascularization
strategy.ovascular Surgery c June 2008Although it may be true that patients with
a history of previous PCI may have a higher
risk of perioperative complications, it is im-
portant to keep in perspective the limitations
of this study. We do, however, agree with
the authors that current evidence supports
revascularization with CABG rather than
PCI in the diabetic population. Despite this
advice, many patients still opt for less-inva-
sive strategies such as PCI in the first
instance. Certainly, the widespread avail-
ability of drug-eluting stents has led to in-
terventional cardiologists tackling more
difficult, previously unfavorable lesions,
not amenable to surgery. Therefore in an
evolving area, it is not unexpected that
surgeons will be confronted with more
challenging patient cohorts.
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